Ipsogen Inc., a fully owned subsidiary of Ipsogen SAS, is a molecular diagnostic company focused on the development and commercialization of innovative diagnostic products to personalize treatment options in cancers. IPSOGEN has built a comprehensive portfolio of unique products in blood cancers available in more than 50 countries all over the world to leading institutions involved in cancer care. IPSOGEN products are registered as IVD in Europe. To further expand its commercial network, Ipsogen has recently concluded agreements with major testing laboratories such as Labcorp® (USA), Warnex Inc. (Canada) or DNA vision (Belgium). IPSOGEN is headquartered in Marseille, France, and has its U.S. offices in New Haven, Connecticut.
| Website | http://www.ipsogen.com |
| Revenue | $12.4 million |
| Employees | View employees |
| Address | 700 Canal St Ste 5, Stamford, Connecticut 06902, US |
| Phone | +1 203-504-8585 |
| Industry | Hospitals & Clinics, Healthcare |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Exact Sciences, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Celerion, OncoQuest Inc +42 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 8071 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Ipsogen Inc. employee's phone or email?
Ipsogen Inc. Questions
The Ipsogen Inc. annual revenue was $12.4 million in 2026.
Ipsogen Inc. is based in Stamford, Connecticut.
The NAICS codes for Ipsogen Inc. are [621, 62].
The SIC codes for Ipsogen Inc. are [80, 8071, 807].
